This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.
Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
Age 18 years and older.
Patients with advanced, unresectable HCC as determined by the treating physician.
Patients with resectable HCC who are still candidates for locoregional therapy
Patients receiving prior systemic or locoregional therapy
Newly diagnosed with advanced hepatocellular carcinoma (HCC) that cannot be removed with surgery.
Cohort
Prospective
Comprehensive Geriatric Assessment (CGA)
Other interventionAssessments will be done for participants that are 65 years or older.
Characterize the Change in disease and treatment patterns of advanced hepatocellular carcinoma (HCC) in older patients in the US.
Collection of the participants disease characteristics, clinical and treatment data. Comprehensive geriatrics assessments will be done using bilingual assessments in English and Spanish.
Click on the lead sponsor to view all of their trials.
